ResApp Provides Updated Top-line Results from SMARTCOUGH-C-2 Study

View printer-friendly version Brisbane, Australia, 18 March 2019 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today provided top-line results for...

ResApp Receives R&D Advanced Overseas Finding

View printer-friendly version Brisbane, Australia, 13 March 2019 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that it has...